{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:47:28Z","timestamp":1791478048070,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12012-026-10090-2","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:10:47Z","timestamp":1768219847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ferric Carboxymaltose Among Patients with Heart Failure and Iron Deficiency: An Updated Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1007","volume":"26","author":[{"given":"Ahmed Elmorsy","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Farid","family":"Gadelmawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyad","family":"Kholeif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsayed","family":"Balbaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameer","family":"Awashra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elnady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Diaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohab","family":"Elnashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haytham A. M.","family":"Dwaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Mohyeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranem","family":"Afify","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Rashwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad","family":"Tahhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam Y.","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"1","key":"10090_CR1","volume":"16","author":"G Savarese","year":"2023","unstructured":"Savarese, G., Becher, P. M., Lund, L. H., Seferovic, P., Rosano, G. M., & Coats, A. J. (2023). Global burden of heart failure: A comprehensive and updated review of epidemiology. Circulation. Cardiovascular Quality and Outcomes, 16(1), Article e013289.","journal-title":"Circulation. Cardiovascular Quality and Outcomes"},{"issue":"7","key":"10090_CR2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","volume":"71","author":"BML Rocha","year":"2018","unstructured":"Rocha, B. M. L., Cunha, G. J. L., & Menezes Falc\u00e3o, L. F. (2018). The burden of iron deficiency in heart failure: Therapeutic approach. Journal of the American College of Cardiology, 71(7), 782\u2013793.","journal-title":"Journal of the American College of Cardiology"},{"key":"10090_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2025.08.012","author":"A Shubietah","year":"2025","unstructured":"Shubietah, A., Elgendy, M. S., Taha, H. I., Awashra, A., Alqadi, M., Olumuyide, E., Abdelhafez, M. O., Zeidalkilani, J., Munshi, H., Qafisheh, Q., & Baniowda, M. A. (2025). Geographic and demographic disparities in left-ventricular failure mortality, 1999\u20132020, with forecasts to 2040: A nationwide US analysis. Archives of Cardiovascular Diseases. https:\/\/doi.org\/10.1016\/j.acvd.2025.08.012","journal-title":"Archives of Cardiovascular Diseases"},{"issue":"2","key":"10090_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/00015385.2017.1351239","volume":"73","author":"P Martens","year":"2018","unstructured":"Martens, P., Nijst, P., Verbrugge, F. H., Smeets, K., Dupont, M., & Mullens, W. (2018). Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction. Acta Cardiologica, 73(2), 115\u2013123.","journal-title":"Acta Cardiologica"},{"issue":"15","key":"10090_CR5","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","volume":"31","author":"EA Jankowska","year":"2010","unstructured":"Jankowska, E. A., Rozentryt, P., Witkowska, A., Nowak, J., Hartmann, O., Ponikowska, B., Borodulin-Nadzieja, L., Banasiak, W., Polonski, L., Filippatos, G., & McMurray, J. J. (2010). Iron deficiency: An ominous sign in patients with systolic chronic heart failure. European Heart Journal, 31(15), 1872\u20131880.","journal-title":"European Heart Journal"},{"issue":"2","key":"10090_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ehf2.12400","volume":"6","author":"A Martin-Malo","year":"2019","unstructured":"Martin-Malo, A., Borchard, G., Fl\u00fchmann, B., Mori, C., Silverberg, D., & Jankowska, E. A. (2019). Differences between intravenous iron products: Focus on treatment of iron deficiency in chronic heart failure patients. ESC Heart Failure, 6(2), 241\u2013253.","journal-title":"ESC Heart Failure"},{"issue":"11","key":"10090_CR7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski, P., van Veldhuisen, D. J., Comin-Colet, J., Ertl, G., Komajda, M., Mareev, V., McDonagh, T., Parkhomenko, A., Tavazzi, L., Levesque, V., & Mori, C. (2015). CONFIRM-HF Investigators. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. European Heart Journal, 36(11), 657\u2013668.","journal-title":"European Heart Journal"},{"issue":"10266","key":"10090_CR8","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","volume":"396","author":"P Ponikowski","year":"2020","unstructured":"Ponikowski, P., Kirwan, B. A., Anker, S. D., McDonagh, T., Dorobantu, M., Drozdz, J., Fabien, V., Filippatos, G., G\u00f6hring, U. M., Keren, A., & Khintibidze, I. (2020). AFFIRM-AHF investigators. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: A multicentre, double-blind, randomised, controlled trial. Lancet, 396(10266), 1895\u20131904.","journal-title":"Lancet"},{"key":"10090_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-025-07807-w","author":"A Shubietah","year":"2025","unstructured":"Shubietah, A., Rakab, M. S., Elgendy, M. S., Ahmed, A., Murad, M. R., Abdul-Hafez, H. A., Zahran, A., Balbaa, E., Awashra, A., Alkhawam, M., & Nazzal, Z. (2025). Clinical outcomes in anemic women undergoing elective percutaneous coronary intervention: A retrospective cohort analysis. Cardiovascular Drugs and Therapy. https:\/\/doi.org\/10.1007\/s10557-025-07807-w","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"37","key":"10090_CR10","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., B\u00f6hm, M., Burri, H., Butler, J., \u010celutkien\u0117, J., Chioncel, O., & Cleland, J. G. (2023). 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. European Heart Journal, 44(37), 3627\u20133639.","journal-title":"European Heart Journal"},{"issue":"18","key":"10090_CR11","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., & Fang, J. C. (2022). 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines. Circulation, 145(18), e895\u20131032.","journal-title":"Circulation"},{"issue":"25","key":"10090_CR12","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., L\u00fcscher, T. F., Bart, B., Banasiak, W., Niegowska, J., & Kirwan, B. A. (2009). Ferric carboxymaltose in patients with heart failure and iron deficiency. New England Journal of Medicine, 361(25), 2436\u20132448.","journal-title":"New England Journal of Medicine"},{"key":"10090_CR13","doi-asserted-by":"crossref","unstructured":"Anker, S. D., Friede, T., Butler, J., Talha, K. M., Placzek, M., Diek, M. (2025). Intravenous ferric carboxymaltose in heart failure with iron deficiency: The FAIR-HF2 DZHK05 randomized clinical trial. JAMA, 2025, e253833.","DOI":"10.1001\/jama.2025.3833"},{"issue":"7","key":"10090_CR14","volume":"17","author":"V Lopez","year":"2025","unstructured":"Lopez, V., Chac\u00f3n, M., Arias, M. J., Rojas, A., Arias, J., Vanegas, P., Rodr\u00edguez, F. A., & Saenz, M. E. (2025). Intravenous iron therapy in patients admitted with acute heart failure and iron deficiency: A systematic review and meta-analysis. Cureus, 17(7), Article e88989.","journal-title":"Cureus"},{"key":"10090_CR15","doi-asserted-by":"publisher","first-page":"178314","DOI":"10.1016\/j.ejphar.2025.178314","volume":"1008","author":"L Shalabi","year":"2025","unstructured":"Shalabi, L., Ibrahim, A., Ramadan, S., Zreigh, S., Shalabi, S., Rifai, M., Awad, A. A., Ahmed, A. M., Legrand, M., & Meyer, D. (2025). Intravenous ferric carboxymaltose for iron deficiency in heart failure patients: A meta-analysis with trial sequential analysis. European Journal of Pharmacology, 1008, 178314.","journal-title":"European Journal of Pharmacology"},{"issue":"3","key":"10090_CR16","first-page":"251","volume":"44","author":"AM Taha","year":"2024","unstructured":"Taha, A. M., Elsaeidy, A. S., Nada, S. A., Sharma, S., Ghonaim, M. M., Ahsan, A., Mourid, M. R., & Abouelmagd, K. (2024). Efficacy of intravenous ferric carboxymaltose in heart failure patients with iron deficiency anemia: A meta-analysis of 6271 patients. Clinical Drug Investigation, 44(3), 251\u2013260.","journal-title":"Clinical Drug Investigation"},{"key":"10090_CR17","doi-asserted-by":"crossref","unstructured":"Higgins, J. P., & Green, S. (Eds.). (2008). Front matter. Cochrane handbook for systematic reviews of interventions (1st ed.). Wiley.","DOI":"10.1002\/9780470712184"},{"issue":"4","key":"10090_CR18","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00059-021-05062-x","volume":"47","author":"J Wintrich","year":"2022","unstructured":"Wintrich, J., Berger, A. K., Bewarder, Y., Emrich, I., Slawik, J., & B\u00f6hm, M. (2022). [Update on diagnostics and treatment of heart failure. Herz, 47(4), 340\u2013353.","journal-title":"Herz"},{"key":"10090_CR19","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne, J. A. C., Savovi\u0107, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H. Y., Corbett, M. S., Eldridge, S. M., & Emberson, J. R. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. Bmj, 366, l4898.","journal-title":"Bmj"},{"issue":"48","key":"10090_CR20","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1093\/eurheartj\/ehab411","volume":"42","author":"P Martens","year":"2021","unstructured":"Martens, P., Dupont, M., Dauw, J., Nijst, P., Herbots, L., Dendale, P., Vandervoort, P., Bruckers, L., Tang, W. H. W., & Mullens, W. (2021). The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy\u2014the IRON-CRT trial. European Heart Journal, 42(48), 4905\u20134914.","journal-title":"European Heart Journal"},{"issue":"11","key":"10090_CR21","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa2304968","volume":"389","author":"RJ Mentz","year":"2023","unstructured":"Mentz, R. J., Garg, J., Rockhold, F. W., Butler, J., De Pasquale, C. G., Ezekowitz, J. A., Lewis, G. D., O\u2019Meara, E., Ponikowski, P., Troughton, R. W., & Wong, Y. W. (2023). Ferric carboxymaltose in heart failure with iron deficiency. New England Journal of Medicine, 389(11), 975\u2013986.","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10090_CR22","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2019-0156","volume":"6","author":"S Dhoot","year":"2020","unstructured":"Dhoot, S., Mittal, S., Singh, S. P., Patel, V., Kasliwal, R. R., & Mehta, V. (2020). Effect of ferric-carboxy maltose on oxygen kinetics and functional status in heart failure patients with iron deficiency. Future Science OA, 6(5), Article FSO467.","journal-title":"Future Science OA"},{"issue":"2","key":"10090_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/ehf2.12250","volume":"5","author":"TJ Yeo","year":"2018","unstructured":"Yeo, T. J., Yeo, P. S., Hadi, F. A., Cushway, T., Lee, K. Y., Yin, F. F., Ching, A., Li, R., Loh, S. Y., Lim, S. L., & Wong, R. C. C. (2018). Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF). ESC Heart Failure, 5(2), 344\u2013353.","journal-title":"ESC Heart Failure"},{"issue":"15","key":"10090_CR24","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","volume":"136","author":"DJ van Veldhuisen","year":"2017","unstructured":"van Veldhuisen, D. J., Ponikowski, P., van der Meer, P., Metra, M., B\u00f6hm, M., Doletsky, A., Voors, A. A., Macdougall, I. C., Anker, S. D., Roubert, B., & Zakin, L. (2017). Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation, 136(15), 1374\u20131383.","journal-title":"Circulation"},{"issue":"6","key":"10090_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17245","volume":"9","author":"M Hamed","year":"2023","unstructured":"Hamed, M., Elseidy, S. A., Ahmed, A., Thakker, R., Mansoor, H., Khalili, H., Mohsen, A., Mamas, M. A., Banerjee, S., Kumbhani, D. J., & Elgendy, I. Y. (2023). Intravenous iron therapy among patients with heart failure and iron deficiency: An updated meta-analysis of randomized controlled trials. Heliyon, 9(6), Article e17245.","journal-title":"Heliyon"},{"issue":"1","key":"10090_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ehf2.14905","volume":"12","author":"M Ahmed","year":"2025","unstructured":"Ahmed, M., Shafiq, A., Javaid, H., Singh, P., Shahbaz, H., Maniya, M. T., Jain, H., Shakir, N., Cheema, H. A., Ahmad, A., & Rehman, W. U. (2025). Intravenous iron therapy for heart failure and iron deficiency: An updated meta-analysis of randomized clinical trials. ESC Heart Failure, 12(1), 43\u201353.","journal-title":"ESC Heart Failure"},{"issue":"1","key":"10090_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11010125","volume":"11","author":"RIS Alnuwaysir","year":"2021","unstructured":"Alnuwaysir, R. I. S., Hoes, M. F., van Veldhuisen, D. J., van der Meer, P., & Beverborg, N. G. (2021). Iron deficiency in heart failure: Mechanisms and pathophysiology. Journal of Clinical Medicine, 11(1), Article 125.","journal-title":"Journal of Clinical Medicine"},{"issue":"7","key":"10090_CR28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s11886-023-01889-4","volume":"25","author":"A Shamsi","year":"2023","unstructured":"Shamsi, A., Cannata, A., Piper, S., Bromage, D. I., & McDonagh, T. A. (2023). Treatment of iron deficiency in heart failure. Current Cardiology Reports, 25(7), 649\u2013661.","journal-title":"Current Cardiology Reports"},{"issue":"5","key":"10090_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/ejhf.2478","volume":"24","author":"J Butler","year":"2022","unstructured":"Butler, J., Khan, M. S., Friede, T., Jankowska, E. A., Fabien, V., Goehring, U. M., Dorigotti, F., Metra, M., Pi\u00f1a, I. L., Coats, A. J., & Rosano, G. (2022). Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency. European Journal of Heart Failure, 24(5), 821\u2013832.","journal-title":"European Journal of Heart Failure"},{"key":"10090_CR30","doi-asserted-by":"crossref","unstructured":"Anker, S. D., Karakas, M., Mentz, R. J., Ponikowski, P., Butler, J., Khan, M. S. (2025). Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency. Nature Medicine, 2025, 1.","DOI":"10.1038\/s41591-025-03671-1"},{"issue":"6","key":"10090_CR31","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1002\/ehf2.13146","volume":"7","author":"MS Khan","year":"2020","unstructured":"Khan, M. S., Usman, M. S., von Haehling, S., Doehner, W., & Stewart Coats, A. J. (2020). Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: A systematic review and meta\u2010analysis. ESC Heart Failure, 7(6), 3392\u20133400.","journal-title":"ESC Heart Failure"},{"issue":"1","key":"10090_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/20565623.2024.2367956","volume":"10","author":"BS Rangwala","year":"2024","unstructured":"Rangwala, B. S., Zuhair, V., Mustafa, M. S., Mussarat, A., Khan, A. W., Danish, F., Fatima Zaidi, S. M., Rehman, F. U., & Shafique, M. A. (2024). Ferric carboxymaltose for iron deficiency in patients with heart failure: A systematic review and meta-analysis. Future Science OA, 10(1), Article 2367956.","journal-title":"Future Science OA"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10090-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10090-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10090-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:34:57Z","timestamp":1769222097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-026-10090-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10090"],"URL":"https:\/\/doi.org\/10.1007\/s12012-026-10090-2","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}